ALK-Abello A/S (AKBLF)
36.14
0.00 (0.00%)
USD |
OTCM |
Dec 10, 16:00
ALK-Abello Total Assets (Quarterly): 1.334B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novo Nordisk A/S | 80.64B |
| Genmab A/S | 7.021B |
| Ascendis Pharma A/S | 1.357B |
| Evaxion AS | 25.24M |
| IO Biotech, Inc. | 39.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 362.20M |
| Shareholders Equity (Quarterly) | 971.70M |
| Debt to Equity Ratio | 0.0752 |
| Current Ratio | 2.564 |
| Net Debt Paydown Yield | -0.00% |